Rapid Dose Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is March - February.

Millions CAD. Fiscal year is Mar - Feb.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '25 Nov 30, 2025	Feb '25 Feb 28, 2025	Feb '24 Feb 29, 2024	Feb '23 Feb 28, 2023	Feb '22 Feb 28, 2022	Feb '21 Feb 28, 2021
Cash & Equivalents	0.11	0.02	0.16	0.03	0.03	0.07
Cash & Short-Term Investments	0.11	0.02	0.16	0.03	0.03	0.07
Cash Growth	172.23%	-87.14%	483.82%	-19.90%	-50.98%	1925.42%
Accounts Receivable	0.2	0.14	0.03	0.06	0.07	0.08
Other Receivables	0.06	0.16	0.19	0.09	0.11	0.17
Receivables	0.26	0.3	0.22	0.15	0.18	0.26
Inventory	0.19	0.26	0.17	0.16	0.28	0.37
Prepaid Expenses	0.04	0.06	0.1	0.06	0.09	0.1
Other Current Assets	0.06	0.03	0.03	0.03	0.03	-
Total Current Assets	0.66	0.66	0.68	0.42	0.61	0.8
Property, Plant & Equipment	3.12	0.97	1.21	1.83	2.45	3.03
Total Assets	3.79	1.63	1.89	2.25	3.07	3.83
Accounts Payable	2.33	1.94	1.12	2.78	1.36	1.83
Accrued Expenses	2.34	2.29	1.47	-	-	-
Short-Term Debt	3.33	2.61	0.21	1.57	0.76	1.23
Current Portion of Long-Term Debt	-	-	0.09	0.19	-	-
Current Portion of Leases	0.24	-	0.03	0.34	0.31	0.29
Current Unearned Revenue	-	-	-	0.01	0.02	0.9
Total Current Liabilities	8.23	6.84	2.92	4.89	2.45	4.25
Long-Term Debt	-	-	2.12	-	-	-
Long-Term Leases	2.2	-	-	0.03	0.36	0.67
Total Liabilities	10.43	6.84	5.04	4.92	2.82	4.92
Common Stock	29.23	28.26	26.61	25.13	25	18.6
Additional Paid-In Capital	6.92	6.65	5.24	4.85	4.15	2.64
Retained Earnings	-47.29	-44.6	-39.26	-34.97	-31.16	-22.67
Comprehensive Income & Other	4.49	4.49	4.24	2.32	2.26	0.34
Shareholders' Equity	-6.65	-5.21	-3.16	-2.67	0.25	-1.09
Total Liabilities & Equity	3.79	1.63	1.89	2.25	3.07	3.83
Total Debt	5.77	2.61	2.45	2.12	1.43	2.19
Net Cash (Debt)	-5.66	-2.59	-2.29	-2.1	-1.4	-2.12
Net Cash Per Share	-0.04	-0.02	-0.02	-0.02	-0.01	-0.03
Filing Date Shares Outstanding	134.82	129.53	122.3	103.57	103.07	80.67
Total Common Shares Outstanding	134.82	129.53	117.81	103.57	103.07	80.67
Working Capital	-7.57	-6.18	-2.24	-4.47	-1.84	-3.45
Book Value Per Share	-0.05	-0.04	-0.03	-0.03	0.00	-0.01
Tangible Book Value	-6.65	-5.21	-3.16	-2.67	0.25	-1.09
Tangible Book Value Per Share	-0.05	-0.04	-0.03	-0.03	0.00	-0.01
Machinery	2.4	2.4	2.39	2.39	2.39	2.21

Source: S&P Global Market Intelligence. Standard template. Financial Sources.